Neuron:帕金森病三十年来新突破!导致运动障碍的罪魁祸首或不是消失的多巴胺

2017-10-22 代丝雨 奇点网

近期发表在《细胞》子刊《神经元》杂志上的一项研究可能要颠覆这一传统认知了。来自韩国科学技术高级研究所(KAIST)和南洋理工大学的科学家发现,增加基底神经节的抑制信号,竟然会让丘脑更加兴奋,从而增加肌肉活动乃至震颤!这也就能解释,为什么很多患者吃了可以增加多巴胺水平的左旋多巴,反倒抖得更加厉害了。

200年前,英国医生James Parkinson描述了一种会不由自主地颤抖的疾病,就是我们现在所说的帕金森病。治疗它的治疗药物有六大类,但是万变不离其宗,它们都是以直接增加脑内多巴胺的水平、或延缓多巴胺的代谢分解为中心来实现治疗目的的。毕竟在大家的认知中,帕金森病的一个主要病理特征就是多巴胺能神经元死亡,多巴胺分泌减少。这导致基底神经节的抑制信号减少,丘脑兴奋的状态就是病因所在。但是!近期发表在《细胞》子刊《神经元》杂志上的一项研究可能要颠覆这一传统认知了。来自韩国科学技术高级研究所(KAIST)和南洋理工大学的科学家发现,增加基底神经节的抑制信号,竟然会让丘脑更加兴奋,从而增加肌肉活动乃至震颤!这也就能解释,为什么很多患者吃了可以增加多巴胺水平的左旋多巴,反倒抖得更加厉害了。棕色为丘脑,紫色为基底神经节基底神经节发出的信号在丘脑汇总,丘脑将运动信号投射到大脑皮层,引起肢体活动大家知道,我们的大脑工作起来是非常复杂的,这个“司令塔”要分成好多个部门。简单来说,“参谋部”基底神经节发出信号,到了“情报中心”丘脑引起神经元的响应,“通信员”大脑皮层得到了动作指令,相应的“执行部队”也就是

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1751853, encodeId=c5451e5185398, content=<a href='/topic/show?id=9b6a12e0155' target=_blank style='color:#2F92EE;'>#Neuron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12701, encryptionId=9b6a12e0155, topicName=Neuron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9c736410065, createdName=by2021, createdTime=Mon Mar 26 01:42:00 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724955, encodeId=9d581e2495577, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58586, encryptionId=9ee758586bb, topicName=新突破)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=792a33728807, createdName=zxxiang, createdTime=Wed Feb 07 06:42:00 CST 2018, time=2018-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368791, encodeId=17271368e9189, content=<a href='/topic/show?id=b40b9423884' target=_blank style='color:#2F92EE;'>#运动障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94238, encryptionId=b40b9423884, topicName=运动障碍)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Tue Oct 24 07:42:00 CST 2017, time=2017-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255465, encodeId=f23c255465fd, content=学长, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/27/e6ae4d6996235d5b5d2f416737192359.jpg, createdBy=ba621669454, createdName=麻醉僧, createdTime=Tue Oct 24 00:04:41 CST 2017, time=2017-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255330, encodeId=5a242553308c, content=已学习并已分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Mon Oct 23 11:37:43 CST 2017, time=2017-10-23, status=1, ipAttribution=)]
    2018-03-26 by2021
  2. [GetPortalCommentsPageByObjectIdResponse(id=1751853, encodeId=c5451e5185398, content=<a href='/topic/show?id=9b6a12e0155' target=_blank style='color:#2F92EE;'>#Neuron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12701, encryptionId=9b6a12e0155, topicName=Neuron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9c736410065, createdName=by2021, createdTime=Mon Mar 26 01:42:00 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724955, encodeId=9d581e2495577, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58586, encryptionId=9ee758586bb, topicName=新突破)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=792a33728807, createdName=zxxiang, createdTime=Wed Feb 07 06:42:00 CST 2018, time=2018-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368791, encodeId=17271368e9189, content=<a href='/topic/show?id=b40b9423884' target=_blank style='color:#2F92EE;'>#运动障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94238, encryptionId=b40b9423884, topicName=运动障碍)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Tue Oct 24 07:42:00 CST 2017, time=2017-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255465, encodeId=f23c255465fd, content=学长, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/27/e6ae4d6996235d5b5d2f416737192359.jpg, createdBy=ba621669454, createdName=麻醉僧, createdTime=Tue Oct 24 00:04:41 CST 2017, time=2017-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255330, encodeId=5a242553308c, content=已学习并已分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Mon Oct 23 11:37:43 CST 2017, time=2017-10-23, status=1, ipAttribution=)]
    2018-02-07 zxxiang
  3. [GetPortalCommentsPageByObjectIdResponse(id=1751853, encodeId=c5451e5185398, content=<a href='/topic/show?id=9b6a12e0155' target=_blank style='color:#2F92EE;'>#Neuron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12701, encryptionId=9b6a12e0155, topicName=Neuron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9c736410065, createdName=by2021, createdTime=Mon Mar 26 01:42:00 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724955, encodeId=9d581e2495577, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58586, encryptionId=9ee758586bb, topicName=新突破)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=792a33728807, createdName=zxxiang, createdTime=Wed Feb 07 06:42:00 CST 2018, time=2018-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368791, encodeId=17271368e9189, content=<a href='/topic/show?id=b40b9423884' target=_blank style='color:#2F92EE;'>#运动障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94238, encryptionId=b40b9423884, topicName=运动障碍)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Tue Oct 24 07:42:00 CST 2017, time=2017-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255465, encodeId=f23c255465fd, content=学长, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/27/e6ae4d6996235d5b5d2f416737192359.jpg, createdBy=ba621669454, createdName=麻醉僧, createdTime=Tue Oct 24 00:04:41 CST 2017, time=2017-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255330, encodeId=5a242553308c, content=已学习并已分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Mon Oct 23 11:37:43 CST 2017, time=2017-10-23, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1751853, encodeId=c5451e5185398, content=<a href='/topic/show?id=9b6a12e0155' target=_blank style='color:#2F92EE;'>#Neuron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12701, encryptionId=9b6a12e0155, topicName=Neuron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9c736410065, createdName=by2021, createdTime=Mon Mar 26 01:42:00 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724955, encodeId=9d581e2495577, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58586, encryptionId=9ee758586bb, topicName=新突破)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=792a33728807, createdName=zxxiang, createdTime=Wed Feb 07 06:42:00 CST 2018, time=2018-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368791, encodeId=17271368e9189, content=<a href='/topic/show?id=b40b9423884' target=_blank style='color:#2F92EE;'>#运动障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94238, encryptionId=b40b9423884, topicName=运动障碍)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Tue Oct 24 07:42:00 CST 2017, time=2017-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255465, encodeId=f23c255465fd, content=学长, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/27/e6ae4d6996235d5b5d2f416737192359.jpg, createdBy=ba621669454, createdName=麻醉僧, createdTime=Tue Oct 24 00:04:41 CST 2017, time=2017-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255330, encodeId=5a242553308c, content=已学习并已分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Mon Oct 23 11:37:43 CST 2017, time=2017-10-23, status=1, ipAttribution=)]
    2017-10-24 麻醉僧

    学长

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1751853, encodeId=c5451e5185398, content=<a href='/topic/show?id=9b6a12e0155' target=_blank style='color:#2F92EE;'>#Neuron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12701, encryptionId=9b6a12e0155, topicName=Neuron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9c736410065, createdName=by2021, createdTime=Mon Mar 26 01:42:00 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724955, encodeId=9d581e2495577, content=<a href='/topic/show?id=9ee758586bb' target=_blank style='color:#2F92EE;'>#新突破#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58586, encryptionId=9ee758586bb, topicName=新突破)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=792a33728807, createdName=zxxiang, createdTime=Wed Feb 07 06:42:00 CST 2018, time=2018-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368791, encodeId=17271368e9189, content=<a href='/topic/show?id=b40b9423884' target=_blank style='color:#2F92EE;'>#运动障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94238, encryptionId=b40b9423884, topicName=运动障碍)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Tue Oct 24 07:42:00 CST 2017, time=2017-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255465, encodeId=f23c255465fd, content=学长, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/27/e6ae4d6996235d5b5d2f416737192359.jpg, createdBy=ba621669454, createdName=麻醉僧, createdTime=Tue Oct 24 00:04:41 CST 2017, time=2017-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255330, encodeId=5a242553308c, content=已学习并已分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Mon Oct 23 11:37:43 CST 2017, time=2017-10-23, status=1, ipAttribution=)]
    2017-10-23 15938038573红旗飘飘

    已学习并已分享

    0

相关资讯

帕金森氏病新疗法:植入猪的脑细胞

你会同意将猪细胞植入自己的大脑吗?有些罹患帕金森氏病的人会同意的,他们希望这种移植能够阻止疾病的进一步发展。这种方法仍处于早期试验阶段,但四位患者的初步试验结果看起来令人满怀希望,他们在术后18个月的时间里均有所改善。帕金森氏病会导致震颤和移动困难,随着时间的推移患者的状况往往会变得更糟。这种疾病是由生成多巴胺的脑细胞逐渐减少引起的,而多巴胺有助于控制我们的运动。目前,该病的疗法是用药物来替代损失

STROKE:脊柱动脉硬化竟然与帕金森相关!

目前,对老年人脊髓微血管病变方面的研究较少。近期,一项发表在杂志STROKE上的研究描述了老年脊髓微血管病变,并检查了这种微血管病变与其他脊髓和脑死亡指数以及帕金森综合征之间的关系。研究者们记录了来自165名已故老年受试者的脊髓和脑标本中微血管病变的3个特征。此外,还测量了脊髓白质苍白。帕金森病征象使用统一的帕金森病评定量表的运动部分的修改版本进行评估。使用控制年龄和性别的回归模型检查了脊髓动脉硬

男人患帕金森风险是女人1.46倍!宣武李勇杰报告“大数据”

首都医科大学宣武医院功能神经外科主任、北京功能神外研究所所长李勇杰教授近日做了关于《立体定向手术治疗运行障碍病-宣武医院20年工作回顾性研究》的学术报告。在过去的20年中,李勇杰教授团队积累了世界最大宗运动障碍病手术量,共完成手术治疗6467例,李勇杰教授的报告公布了基于这份数据的研究与分析,是难得的运动障碍病外科治疗“大数据”。

Lancet Neurol:新确诊帕金森病患者运动障碍进展的临床和遗传预测模型研究

研究确定了帕金森病运动障碍进展的预测因子,该模型将有益于临床试验的设计和评估,以及临床疾病的监测和治疗

中国在帕金森治疗上与美国并肩:还可网络远程诊疗

中国网络科技的快速发展,让远在千里之外、身处异国的帕金森患者,在有WiFi或4G网络和一台电脑的情况下,就可以接受手术后远程诊疗。北京天坛医院功能神经外科主任张建国说,手术后远程诊疗,是中国治疗帕金森症其中一项创新功能,而更为关键的是,脑起搏器在中国国产化后价格的降低以及技术上的改进提升,让全球更多的帕金森患者有条件进行植入手术。“左侧大脑电压增加1伏,右脉宽加到70,频率不变。”北京天坛医院神经

Neurology:帕金森病人接受睡眠状态下脑深部电刺激有益于病情缓解

研究认为,对于帕金森患者进行睡眠状态下的脑深部电刺激更有利于患者6个月的运动功能改善